Who are Artivion, Inc.'s major customers?

Artivion, Inc. (AORT) key customers include: Abbott Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Becton, Dickinson and Company, Johnson & Johnson and 9 more. View the full customer network at chainsifter.com/chain/AORT.

What sector is Artivion, Inc. in?

Artivion, Inc. (AORT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Artivion, Inc. (AORT) Supply Chain: 16 Verified Relationships

0Suppliers

14Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Artivion, Inc. (AORT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

17Total relationships

1Distinct source URLs

3High confidence

0.705Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Artivion, Inc. Suppliers

No suppliers on recordArtivion, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Artivion, Inc. Customers

Ticker	Name	Confidence	Evidence
ABT	Abbott Laboratories	72%	Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operati…
ABT	Abbott Laboratories	72%	r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
BDX	Becton, Dickinson and Company	72%	Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: Reciprocal relationship from BDX grap…
BDX	Becton, Dickinson and Company	72%	r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
JNJ	Johnson & Johnson	72%	r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ grap…
BAX	Baxter International Inc.	62%	Reciprocal relationship from BAX graph: Reciprocal relationship from AORT graph: . Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes…
BAXTER-INTERNATIONAL-INC	BAXTER-INTERNATIONAL-INC	62%	. Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en…
COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR	COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR	62%	r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
DELAWARE-GENERAL-CORPORATION	DELAWARE-GENERAL-CORPORATION	62%	declare all indebtedness outstanding, together with accrued and unpaid interest and fees, to be due and payable and terminate all commitments to extend further credit, if applicable. If we are unable…
DERIVATIVES-ASSOCIATION-INC	DERIVATIVES-ASSOCIATION-INC	62%	able regulations or guidance or impact us in other ways we cannot anticipate. This could delay clinical trials and product launches, impact the regulatory status of current products or services, or a…
GRENA-LIMITED	GRENA-LIMITED	62%	r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh…
JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE	JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE	62%	about the timing and results of our clinical trials, approvals, and product commercialization and launches; • Our expectations related to anticipated expansion of our business and the sufficiency of …
STARCH-MEDICAL-INC	STARCH-MEDICAL-INC	62%	. Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en…

Artivion, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
AORT-DEBT	Debt stack $363.4M	90%	Market cache reports total debt of $363.4M.
AORT-DEBT-7781	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Artivion, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Artivion, Inc..

Artivion, Inc. Ownership

Holder	Name	Confidence	Evidence
AORT-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 240 tracked holders.

Artivion, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ATRA	Atara Biotherapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
ANGO	AngioDynamics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
SVA	Sinovac Biotech Ltd.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
GCTK	GlucoTrack, Inc.	100.00	2
BAX	Baxter International Inc.	100.00	1	['customer']
GRAL	GRAIL, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ALVO	Alvotech	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2

Artivion, Inc. Supply Chain